30 likes | 243 Views
The AMC MACH program: LVAD in the catheterization laboratory and beyond. STEMI patient in cardiogenic shock or preshock?. Is IABP support enough?. Percutaneous LVAD therapy. Improvement / responder to mechanical support. Destination therapy. Nonresponder. Recovery. Recovery.
E N D
The AMC MACH program: LVAD in the catheterization laboratory and beyond STEMI patient in cardiogenic shock or preshock? Is IABP support enough? Percutaneous LVAD therapy Improvement / responder to mechanical support Destination therapy Nonresponder Recovery Recovery Surgical LVAD therapy Bridge to heart transplantation
Figure 1 The AMC MACH program: LVAD in the catheterization laboratory and beyond. The program was initially started with a focus on the treatment on patients with acute myocardial infarction presenting with poor hemodynamics. This simple and unspecified flow chart directs all AMC departments towards upgrading hemodynamic support according to the circulatory need of the patient. Patients who dieon maximum support or do or not show signs of organ preservation are considered to be ‘nonresponders’. In contrast, ‘responders’ either recover completely or recover organ and cerebral function and qualify for further surgical mechanical support if necessary. Abbreviations: AMC MACH, Academic Medical Center Mechanical support for Acute Congestive Heart failure in STEMI patients; IABP, intra-aortic balloon counterpulsation; LVAD, left ventricular assist device; STEMI, ST-segment elevation myocardial infarction.